Achieve Life Sciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $19.5M | $47.5M | $43.0M |
| FY2022 | $21.7M | $30.0M | $24.8M |
| FY2023 | $20.8M | $19.4M | $15.5M |
| FY2024 | $17.7M | $38.6M | $12.8M |
| FY2025 | $20.3M | $41.8M | $20.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $19.5M | $47.5M | $43.0M |
| FY2022 | $21.7M | $30.0M | $24.8M |
| FY2023 | $20.8M | $19.4M | $15.5M |
| FY2024 | $17.7M | $38.6M | $12.8M |
| FY2025 | $20.3M | $41.8M | $20.9M |